Friday 16th May 2025

13:45  Welcome and introduction   (A. Omlin, Zürich)

Renal Cell Carcinoma (RCC)

14:00  Clear cell RCC: state of the art of systemic therapy (C. Rothermundt, Luzern)

14:30  Non-clear cell RCC: state of the art of systemic therapy (A. Lorch, Zürich)

15:00  Surgical options in advanced RCC (primary tumour, metastases) (C. Fankhauser, Luzern)

15:30  Case Discussion (Moderation: Chairs)

15:50  Coffee break

General and Testicular

16:20   Molecular tests in uro-oncology – what is the state of the art? (T. Vlajnic, Basel)

16:50  Genetic counselling and testing in uro-oncology – which patients and what to test? (A. Omlin, Zürich)

17:20  Testicular cancer – Management of acute and long-term toxicities (J. Beyer, Bern)

17:50   Case discussion (Moderation: Chairs)

18:15  Adjourn and Dinner   

Saturday 17th May 2025

Prostate Cancer

08:30   Prostate cancer early detection 2025 – How to do it? (T. Hermanns, Zürich)

09:00   The state of the art of endocrine therapies (ADT and/or ARPI) in advanced prostate cancer (K. Reichel, Zürich)

09:30  How to best use radioligand therapy in advanced prostate cancer? (W. Fendler, Essen)

10:00   Case discussion (Moderation: Chairs)

10:30  Coffee break

Urothelial Carcinoma

11:00  Management of non-muscle invasive urothelial carcinoma  - state of the art? (C. Rentsch, Basel)

11:30  Muscle invasive urothelial carcinoma – what is the state of the art? (M. De Santis, Berlin)

12:30  Locally advanced and metastatic urothelial carcinoma – how to best use systemic therapy options? (S. Aeppli, St. Gallen)

12:30   Award for best case presentation (A. Omlin, Zürich)

12:45  End